Härdig Y, Hillarp A, Dahlbäck B
Department of Clinical Chemistry, Lund University, University Hospital, Malmö, S-205 02 Malmö, Sweden.
Biochem J. 1997 Apr 15;323 ( Pt 2)(Pt 2):469-75. doi: 10.1042/bj3230469.
C4b-binding protein (C4BP) regulates the classical pathway C3-convertase of the complement system. Human C4BP is composed of seven identical subunits (alpha-chains) and one unique one (beta-chain). Both types of chains contain homologous repeats called complement control proteins (CCPs); the alpha-chain contains eight CCPs and the beta-chain three. Each alpha-chain contains a binding site for C4b although the detailed localization of this binding site is not known. We have used three different chimeric proteins, originally designed to localize the protein S-binding site on C4BP, to demonstrate the importance of the amino-terminal part of the alpha-chain for the complement-regulatory functions of C4BP. These recombinant proteins were composed of C4BP alpha-chains with one, two or three of the amino-terminal CCPs replaced by corresponding CCPs from the C4BP beta-chain. Furthermore, seven different monoclonal antibodies were raised against C4BP and characterized using the recombinant chimeric proteins. Whereas all three recombinant chimeras bind protein S with the same affinity as plasma-purified C4BP, none of them bound to C4b. Three of the antibodies, which were found to bind to alpha-chain CCP 1 and CCP 2, completely inhibited the binding of plasma-purified C4BP to immobilized C4b. In addition, two of these antibodies totally blocked the factor I-cofactor activity of C4BP in a C4b-degradation assay. The binding site for one of the monoclonal antibodies was also studied using electron microscopy where it was confirmed that this antibody bound to the amino-terminal tip of the alpha-chain. These results show that the amino-terminal CCP of the C4BP alpha-chain (CCP 1) is crucial for the C4b binding and factor I-cofactor activity.
C4b结合蛋白(C4BP)调节补体系统的经典途径C3转化酶。人C4BP由七个相同的亚基(α链)和一个独特的亚基(β链)组成。两种链都含有称为补体控制蛋白(CCP)的同源重复序列;α链含有八个CCP,β链含有三个。每个α链都含有一个C4b结合位点,尽管该结合位点的详细定位尚不清楚。我们使用了三种不同的嵌合蛋白,最初设计用于定位C4BP上的蛋白S结合位点,以证明α链的氨基末端部分对C4BP补体调节功能的重要性。这些重组蛋白由C4BPα链组成,其中一个、两个或三个氨基末端CCP被来自C4BPβ链的相应CCP取代。此外,针对C4BP产生了七种不同的单克隆抗体,并使用重组嵌合蛋白进行了表征。虽然所有三种重组嵌合体都以与血浆纯化的C4BP相同的亲和力结合蛋白S,但它们都不与C4b结合。发现三种与α链CCP 1和CCP 2结合的抗体完全抑制了血浆纯化的C4BP与固定化C4b的结合。此外,在C4b降解试验中,其中两种抗体完全阻断了C4BP的因子I辅助因子活性。还使用电子显微镜研究了其中一种单克隆抗体的结合位点,证实该抗体与α链的氨基末端结合。这些结果表明,C4BPα链的氨基末端CCP(CCP 1)对于C4b结合和因子I辅助因子活性至关重要。